Brent Richards

@brent-richards.bsky.social

Endocrinologist, geneticist and entrepreneur just trying to help my patients. Prof at McGill and CEO of 5Prime Sciences

At @5PrimeSciences, giving back is part of who we are. This year, our team chose to support @MSF —to deliver critical medical care in humanitarian crises. We’re proud to have joined the Pledge 1% Movement, committing 1% of our profits each year to health and education charities

Our paper out in JCEM showing bias that can creep into Mendelian randomization studies via: 1. Collider bias due to participant selection 2. Indirect genetic effects 3. Collider bias due to GxE effects in nonlinear MR. Led by the great Tianyuan Lu academic.oup.com/jcem/article...

No More Free Lunch: Challenges to Mendelian Randomization Due to Sample Selection and Complex Methods

Abstract. Mendelian randomization (MR) is increasingly used in epidemiological studies to investigate causal relationships. MR depends on 3 fundamental ins

academic.oup.com

Atul Butte died yesterday. The world lost a giant. A big bear of a man. With a huge smile. With love for everyone. With energy that could power a room. I loved everything about Atul. I loved how he was always happy. I loved how excited he was about science and helping people.

Bild

To the world: We are fighting back. Our movement has been silenced by the media here—but we are not backing down. This is what our streets looked like across multiple cities. Tomorrow, there will be more of us! Raise a glass to freedom. —With love, Your American allies.

Is there a German word for being simultaneously horrified by clumsy, misguided, and deeply destructive attacks on a critical system, and by the many grossly dysfunctional and inefficient aspects of the system being attacked? Because we really need one right now.

📣Excited to share our paper in Nature Genetics! rdcu.be/d7mo0 Do plasma proteins mediate obesity’s effect on CAD risk? →Using two-step proteome-wide MR, domain-aware MR, epigenomics & scRNA-seq, we prioritized endotrophin, cleaved from COL6A3, as a mediator & potential therapeutic target. A 🧵↓

Bild

Excited to announce our 17th team member to @5PrimeSciences Kelly Agnew joins us as a Senior Software Engineer to help us build Centromere, our data and analytics engine for genetics-enabled drug development. Welcome Kelly!